APA (7th ed.) Citation

Wang, J., & Li, B. (2023). Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2023 edition). Precision Radiation Oncology, 7(3), 150. https://doi.org/10.1002/pro6.1201

Chicago Style (17th ed.) Citation

Wang, Jun, and Baosheng Li. "Chinese Expert Consensus on the Application of Pegylated Recombinant Human Granulocyte Colony‐stimulating Factor During Concurrent Chemoradiotherapy (2023 Edition)." Precision Radiation Oncology 7, no. 3 (2023): 150. https://doi.org/10.1002/pro6.1201.

MLA (9th ed.) Citation

Wang, Jun, and Baosheng Li. "Chinese Expert Consensus on the Application of Pegylated Recombinant Human Granulocyte Colony‐stimulating Factor During Concurrent Chemoradiotherapy (2023 Edition)." Precision Radiation Oncology, vol. 7, no. 3, 2023, p. 150, https://doi.org/10.1002/pro6.1201.